Hematology
Most hematological disorders have a known genetic component, so genetic diagnosis allows a differential analysis to determine the disease presented by these patients.
Home / Targeted exome sequencing / Hematology
Clinical areas
Documentation
Hemostasis I: 5 studies
Hemostasis is a complex process involving the coordinated interaction of platelets, clotting factors, and the fibrinolytic system. The targeted exome tests we offer are designed to investigate disorders that affect the mechanisms responsible for the balance between clotting and bleeding, and include various types of bleeding disorders, platelet disorders, and thrombophilias.
DG Hemostasis (187 genes)
A2ML1, ABCC6, ABCG5, ABCG8, ACP5, ACTA2, ACTB, ACTN1, ACVRL1, ADA2, ADAMTS13, ALPK3, ANKRD26, ANO6, ANTXR1, AP3B1, AP3D1, APOH, APP, ARHGEF17, ARPC1B, BLOC1S3, BLOC1S5, BLOC1S6, BMP10, BMPR1A, BMPR2, BRAF, CBL, CCM2, CD36, CDC42, CHST14, COL1A1, COL3A1, COL4A1, COL4A2, COL5A1, COL5A2, CYCS, DDAH2, DIAPH1, DTNBP1, ELMO2, ELN, ENG, EPHB2, EPHB4, ETV6, F10, F11, F12, F13A1, F13B, F2, F2R, F3, F5, F7, F8, F9, FERMT3, FGA, FGB, FGG, FLI1, FLNA, FLT4, FYB1, GALE, GATA1, GBA1, GDF2, GFI1b, GFI1B, GGCX, GNAQ, GNE, GP1BA, GP1BB, GP6, GP9, GUCY1A1, HOXA11, HPS1, HPS3, HPS4, HPS5, HPS6, HRAS, IKZF5, IL6, ITGA2, ITGA2B, ITGB3, JAG1, JAK2, KAT6B, KDR, KDSR, KIF15, KLKB1, KNG1, KRAS, KRIT1, LMAN1, LYST, LZTR1, MAP2K1, MAP2K2, MAP3K8, MASTL, MCFD2, MECOM, MPIG6B, MPL, MRTFA, MYH9, NBEA, NBEAL2, NF1, NRAS, NRP2, ORAI1, P2RX1, P2RY12, PCNT, PDCD10, PIK3CA, PLA2G4A, PLAT, PLAU, PPP1CB, PRKACG, PROZ, PTGS1, PTPN11, PTPRJ, RAF1, RAP1B, RASA1, RASA2, RASGRP2, RBM8A, RGS2, RIT1, RNF213, RRAS, RUNX1, SAMHD1, SERPINE1, SERPINE2, SERPINF2, SHOC2, SLC2A10, SLC45A2, SLFN14, SMAD1, SMAD4, SOS1, SOS2, SOX17, SPRED1, SPRY1, SRC, STIM1, STXBP2, SYNGAP1, TBXA2R, TBXAS1, TEK, THBD, THPO, THSD1, TNXB, TPM4, TRPM7, TUBA8, TUBB1, UNC13D, VIPAS39, VKORC1, VPS33B, VWF, WAS, WDR1, WIPF1.
DG Bleeding Disorders (49 genes)
ACTN1, ACVRL1, ANO6, CD36, ENG, EPHB2, F10, F11, F12, F13A1, F13B, F2, F3, F5, F7, F8, F9, FGA, FGB, FGG, FLI1, GDF2, GFI1B, GGCX, GP1BA, GP1BB, GP6, GP9, ITGA2B, ITGB3, KLKB1, KNG1, LMAN1, MCFD2, NBEAL2, P2RY12, PLAU, PRKACG, PROZ, RASGRP2, SERPINE1, SERPINE2, SERPINF2, SLFN14, SMAD4, TBXA2R, TPM4, VKORC1, VWF.
DG Platelet Dysfunction (89 genes)
ABCG5, ABCG8, ACP5, ACTB, ACTN1, ADAMTS13, ANKRD26, ANO6, AP3B1, AP3D1, ARPC1B, BLOC1S3, BLOC1S5, BLOC1S6, BRAF, CD36, CDC42, CYCS, DIAPH1, DTNBP1, EPHB2, ETV6, FLI1, FLNA, FYB1, GALE, GATA1, GFI1b, GFI1B, GNE, GP1BA, GP1BB, GP6, GP9, HOXA11, HPS1, HPS3, HPS4, HPS5, HPS6, HRAS, IKZF5, ITGA2, ITGA2B, ITGB3, JAK2, KIF15, KRAS, LYST, MASTL, MECOM, MPIG6B, MPL, MYH9, NBEAL2, NRAS, ORAI1, P2RY12, PLA2G4A, PLAU, PRKACG, PTPN11, PTPRJ, RAF1, RAP1B, RASA1, RASA2, RASGRP2, RBM8A, RIT1, RRAS, RUNX1, SHOC2, SLFN14, SOS1, SOS2, SPRED1, SRC, STIM1, TBXA2R, TBXAS1, THPO, TPM4, TRPM7, TUBA8, TUBB1, WAS, WDR1, WIPF1.
DG Thrombophilia (36 genes)
ADAMTS13, ALOX5AP, CALR, CBS, F10, F12, F13A1, F13B, F2, F3, F5, F7, F8, F9, FGA, FGB, FGG, HABP2, HRG, MPL, MTHFR, PIGA, PLAT, PLG, PROC, PROCR, PROS1, PROZ, SERPINA10, SERPINC1, SERPIND1, SERPINE1, SH2B3, TFPI, THBD, THPO.
Type I and Type II Thrombophilia (polymorphisms in the F2 and F5 genes) (2 genes)
F5 1601G>A (c.1601G>A), F2 20210G>A (c.*97G>A).
Information
-
Analysis: SNVs, Indels and CNVs -
Medium coverage: >100X -
Delivery time: 30 working days
Erythrocytosis I: 1 study
Erythrocytosis is defined as an increase in the number of red blood cells and, consequently, in hemoglobin levels due to heightened erythropoiesis. Through this targeted exome analysis, we examine the genes associated with various types of erythrocytosis, as well as polycythemia vera, a condition included in the differential diagnosis of erythrocytosis.
DG Erythrocytosis (13 genes)
BPGM, EGLN1, EPAS1, EPO, EPOR, HBA1, HBA2, HBB, JAK2, PIEZO1, SH2B3, SLC30A10, VHL.
Information
-
Analysis: SNVs, Indels and CNVs -
Medium coverage: >100X -
Delivery time: 30 working days
Anemia I: 12 studies
Anemias are a diverse group of disorders characterized by a decrease in the number or size of red blood cells or in their hemoglobin levels. Through various targeted exome sequencing approaches, we investigate the major inherited anemias, such as sideroblastic, dyserythropoietic, aplastic, hemolytic, and megaloblastic anemias.
DG Anemias (273 genes)
ABCB6, ABCB7, ABCD4, ABCG5, ABCG8, ACD, ADA, ADA2, ADAMTS13, ADH5, AK1, ALAD, ALAS2, ALDOA, AMMECR1, AMN, ANK1, ATP11C, ATP7B, BPGM, BRCA1, BRCA2, BRIP1, C3, CASP10, CD19, CD27, CD40LG, CD46, CD59, CD81, CDAN1, CDIN1, CFB, CFH, CFHR1, CFHR3, CFI, CIITA, CISD2, COL4A1, COX4I2, CPOX, CR2, CTC1, CTLA4, CUBN, CYB5A, CYB5R3, DCLRE1B, DGKE, DHFR, DKC1, DNAJC21, DNASE1, DUT, EFL1, ELANE, ELF1, ENO1, EPB41, EPB42, EPO, ERCC4, FAAP100, FANCA, FANCB, FANCC, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCL, FANCM, FAS, FASLG, FCGR2A, FCGR2B, FECH, FOXP3, FTCD, FZD6, G6PD, GALT, GATA1, GATA2, GCLC, GFI1, GLRX5, GP1BA, GP1BB, GP9, GPI, GPX1, GSR, GSS, GYPC, HBA1, HBA2, HBB, HBD, HBG1, HBG2, HCFC1, HEATR3, HK1, HLA-DRB1, HMOX1, HOXA11, HPRT1, HSCB, HSPA9, ICOS, IFNG, IL2RA, IL2RB, KCNN4, KDM6A, KIF23, KLF1, KMT2D, KRAS, LARS2, LAT, LCAT, LDHA, LMBRD1, LMX1B, LPIN2, LRBA, MAD2L2, MIF, MMACHC, MMADHC, MPL, MS4A1, MTHFD1, MTR, MTRR, MTTP, NAF1, NBN, NDUFB11, NFKB1, NFKB2, NHLRC2, NHP2, NLRP1, NOP10, NPM1, NRAS, NT5C3A, PALB2, PARN, PFKM, PGK1, PGM3, PIEZO1, PIGA, PIGM, PIGT, PKLR, PNP, POT1, PRDX1, PRF1, PRKCD, PTPN22, PUS1, RACGAP1, RAD51, RAD51C, RAG1, RAG2, RASGRP1, RFWD3, RFX5, RFXANK, RFXAP, RHAG, RHCE, RHD, RPA1, RPL11, RPL15, RPL17, RPL18, RPL19, RPL26, RPL27, RPL31, RPL35, RPL35A, RPL5, RPL8, RPL9, RPS10, RPS15, RPS15A, RPS15a, RPS17, RPS19, RPS20, RPS24, RPS26, RPS27, RPS27A, RPS28, RPS29, RPS7, RTEL1, SAMD9, SAMD9L, SBDS, SEC23B, SF3B1, SLC11A2, SLC19A1, SLC19A2, SLC25A38, SLC2A1, SLC46A1, SLC4A1, SLX4, SOD1, SPTA1, SPTB, SRP54, SRP72, STAT1, STAT3, STAT4, STEAP3, STIM1, STN1, TCIRG1, TCN2, TERT, TET2, TF, THAP11, THBD, THPO, TINF2, TMPRSS6, TNFAIP3, TNFRSF13B, TNFRSF13C, TNFRSF4, TPI1, TPP2, TREX1, TRNT1, TSR2, TTC7A, TYMS, UBE2T, UMPS, UROD, UROS, USB1, VPS4A, WAS, WFS1, WIPF1, WRAP53, XIAP, XK, XRCC2, YARS2, ZAP70, ZCCHC8.
DG Sideroblastic Anemia (19 genes)
ABCB7, ALAS2, CISD2, FECH, GATA1, GLRX5, HSCB, HSPA9, LARS2, PUS1, SF3B1, SLC19A2, SLC25A38, STEAP3, TET2, TRNT1, UROS, WFS1, YARS2.
DG Congenital dyserythropoietic anemia (10 genes)
CDAN1, CDIN1, COX4I2, GATA1, KIF23, KLF1, LPIN2, RACGAP1, SEC23B, VPS4A.
DG Aplastic Anemia (106 genes)
ACD, ADA2, ALAS2, BRCA1, BRCA2, BRIP1, CD27, CDAN1, CDIN1, COX4I2, CTC1, DCLRE1B, DKC1, DNAJC21, DUT, EFL1, ELANE, ELF1, EPO, ERCC4, FAAP100, FANCA, FANCB, FANCC, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCL, FANCM, FZD6, GATA1, GATA2, GFI1, HEATR3, HOXA11, IFNG, KIF23, KLF1, LMX1B, LPIN2, MAD2L2, MPL, NAF1, NBN, NHP2, NOP10, NPM1, PALB2, PARN, PIGA, POT1, PRF1, RAD51, RAD51C, RFWD3, RPA1, RPL11, RPL15, RPL17, RPL18, RPL19, RPL26, RPL27, RPL31, RPL35, RPL35A, RPL5, RPL8, RPL9, RPS10, RPS15, RPS15A, RPS15a, RPS17, RPS19, RPS20, RPS24, RPS26, RPS27, RPS27A, RPS28, RPS29, RPS7, RTEL1, SAMD9, SAMD9L, SBDS, SEC23B, SLX4, SRP54, SRP72, STN1, TCIRG1, TERT, THPO, TINF2, TSR2, TYMS, UBE2T, USB1, WRAP53, XIAP, XRCC2, ZCCHC8.
Diamond-Blackfan anemia (29 genes)
ADA2, EPO, GATA1, HEATR3, RPL11, RPL15, RPL18, RPL26, RPL27, RPL31, RPL35, RPL35A, RPL5, RPL8, RPL9, RPS10, RPS15, RPS15A, RPS17, RPS19, RPS20, RPS24, RPS26, RPS27, RPS27A, RPS28, RPS29, RPS7, TSR2.
Congenital dyskeratosis (23 genes)
ACD, CTC1, DCLRE1B, DKC1, DNAJC21, DUT, FZD6, LMX1B, NAF1, NHP2, NOP10, NPM1, PARN, POT1, RPA1, RTEL1, STN1, TERT, TINF2, TYMS, USB1, WRAP53, ZCCHC8.
Fanconi anaemia (23 genes)
BRCA1, BRCA2, BRIP1, ERCC4, FANCA, FANCB, FANCC, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCL, FANCM, FAAP100, MAD2L2, PALB2, RAD51, RAD51C, RFWD3, SLX4, UBE2T, XRCC2.
DG Hemolytic Anemia (41 genes)
ABCG8, AK1, ALDOA, AMMECR1, ANK1, BPGM, CYB5A, CYB5R3, ENO1, EPB41, EPB42, G6PD, GATA1, GCLC, GPI, GPX1, GSR, GSS, GYPC, HBA1, HBA2, HBB, HBD, HBG1, HBG2, HK1, HMOX1, KCNN4, KLF1, LDHA, NT5C3A, PFKM, PGK1, PIEZO1, PKLR, RHAG, SLC4A1, SOD1, SPTA1, SPTB, TPI1.
DG Red Blood Cell Membrane Abnormalities (12 genes)
ABCG8, AMMECR1, ANK1, EPB41, EPB42, GYPC, KCNN4, PIEZO1, RHAG, SLC4A1, SPTA1, SPTB.
DG Erythroenzymopathies (21 genes)
AK1, ALDOA, BPGM, CYB5A, CYB5R3, ENO1, G6PD, GCLC, GPI, GPX1, GSR, GSS, HK1, HMOX1, LDHA, NT5C3A, PFKM, PGK1, PKLR, SOD1, TPI1.
DG Haemoglobinopathies (10 genes)
CYB5A, CYB5R3, GATA1, HBA1, HBA2, HBB, HBD, HBG1, HBG2, KLF1.
DG Megaloblastic Anemia (20 genes)
ABCD4, AMN, CUBN, DHFR, FTCD, HCFC1, HPRT1, LMBRD1, MMACHC, MMADHC, MTHFD1, MTR, MTRR, PRDX1, SLC19A1, SLC19A2, SLC46A1, THAP11, UMPS, WFS1.
Information
-
Analysis: SNVs, Indels and CNVs -
Medium coverage: >100X -
Delivery time: 30 working days
Porphyrias I: 1 study
Porphyrias are a group of inherited metabolic disorders caused by abnormalities in the enzymes involved in the heme biosynthesis pathway. This targeted exome test analyzes the genes associated with this condition.
DG Porphyrias (12 genes)
ALAD, ALAS2, CLPX, CPOX, FAH, FECH, GATA1, HFE, HMBS, PPOX, UROD, UROS.
Information
-
Analysis: SNVs, Indels and CNVs -
Medium coverage: >100X -
Delivery time: 30 working days
Iron Metabolism I: 2 studies
Iron metabolism disorders are caused by imbalances in the homeostasis of iron, an element that is essential for the body. Since iron is essential for the proper functioning of hemoglobin, a deficiency can lead to hematological disorders such as anemia. We offer a targeted exome test that analyzes the genes involved in various iron metabolism disorders, as well as a specific test to analyze the three variants most frequently associated with hemochromatosis.
DG Iron Metabolism (49 genes)
ABCB7, ALAS2, ATP13A2, ATP7B, B2M, BMP2, BMP6, C19orf12, CDAN1, CDIN1, CISD2, COX4I2, CP, FA2H, FECH, FTH1, FTL, GATA1, GBA1, GLRX5, HAMP, HEPH, HFE, HJV, HSCB, HSPA9, KIF23, KLF1, LARS2, LPIN2, PANK2, PLA2G6, PUS1, SEC23B, SF3B1, SLC11A2, SLC19A2, SLC25A38, SLC40A1, STAB1, STEAP3, TF, TFR2, TMPRSS6, TRNT1, UROS, WDR45, WFS1, YARS2.
Hemochromatosis (C282Y, H63D, S65C in the HFE gene) (1 gene)
C282Y, H63D, and S65C in the HFE gene.
Information
-
Analysis: SNVs, Indels and CNVs -
Medium coverage: >100X -
Delivery time: 30 working days